Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).
Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy.
Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis.
Forsythiaside A Exhibits Anti-inflammatory Effects in LPS-Stimulated BV2 Microglia Cells Through Activation of Nrf2/HO-1 Signaling Pathway.
Acute disseminated encephalomyelitis in children: a single institution experience of 28 patients.
Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis.
TAPP1 inhibits the differentiation of oligodendrocyte precursor cells via suppressing the Mek/Erk pathway.
Role of statins in the treatment of multiple sclerosis.
IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotection.
Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function.
Association of multiple sclerosis susceptibility variants and early attack location in the CNS.
Extension Trial Data Shows Cladribine Benefits Persist in RRMS Patients
Epidermal pigmentation in the human lineage is an adaptation to ultraviolet radiation.
In vitro assessment of the direct effect of laquinimod on basic functions of human neural stem cells and oligodendrocyte progenitor cells.
The safety of exercise training in multiple sclerosis: A systematic review.
Chronic cerebrospinal venous insufficiency: Case-control neurosonography results.
Investigational Laquinimod Demonstrates Its Potential as a New Oral Treatment For RRMS
Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims Analysis.
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.
Histamine and neuroinflammation: insights from murine experimental autoimmune encephalomyelitis.
Transverse myelitis.
Isolated trigeminal nerve palsy with motor involvement as a presenting manifestation of multiple sclerosis in an equatorial region - a case report.
Report of Three Cases of Herpes Zoster During Treatment with Natalizumab.
Fampridine – Benefit assessment according to § 35a Social Code Book V
Oligoclonal band and multiple sclerosis risk in monosymptomatic optic neuritis patients: a retrospective study of 84 patients.
Pages
« first
‹ previous
…
133
134
135
136
137
138
139
140
141
…
next ›
last »